CRISPR THERAPEUTICS AG (CRSP) Net income 2016–2025
CRISPR THERAPEUTICS AG (CRSP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$581.6MFY2025 · since FY2016: -$23.2M → -$581.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$581.6M | -58.8% |
| FY2024 | -$366.3M | -138.4% |
| FY2023 | -$153.6M | +76.4% |
| FY2022 | -$650.2M | -272.2% |
| FY2021 | $377.7M | +208.3% |
| FY2020 | -$348.9M | -621.8% |
| FY2019 | $66.9M | +140.5% |
| FY2018 | -$165.0M | -141.4% |
| FY2017 | -$68.4M | -194.9% |
| FY2016 | -$23.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice